36 unknown. 36 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 36 | Unknown 36 |
| Phase 3 | 1 | Unknown 1 |
Follow Endostar: new trials by email Literature Review of Endostar trials Research Report on Endostar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors Envafolimab Injection, Endostar - Gastrointestinal Neoplasms | Phase 2 | Unknown | Nanjing First Hospital, Nanjing Medical University | 16 | 2024-02-21 | 2024-03-08 |
| Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Envafolimab, Endostar, Nab paclitaxel - Advanced Pancreatic Cancer | Phase 2 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 20 | 2022-04-01 | 2022-03-28 |
| Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC Envafolimab, Endostar - Lung Neoplasms | Phase 2 | Unknown | The First People's Hospital of Lianyungang | 40 | 2022-03-01 | 2023-06-22 |
| Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Endostar - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Jiangxi Provincial Cancer Hospital | 30 | 2021-07-28 | 2022-01-04 |
| Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma Endostar, Toripalimab - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 2 | Unknown | Fudan University | 43 | 2020-04-01 | 2023-06-22 |
| Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC Camrelizumab - Non-small Cell Lung Cancer | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 52 | 2019-12-31 | 2020-03-10 |
| CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer Radiotherapy, Endostar, Cisplatin - Cervical Cancer | Phase 2 | Unknown | Zhejiang Cancer Hospital | 82 | 2019-08-01 | 2019-10-10 |
| Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors second-line chemotherapy, Recombinant human endostatin - Head and Neck Neoplasms | Phase 2 | Unknown | Sun Yan | 53 | 2019-07-29 | 2020-10-23 |
| Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma Endostar, Cisplatin, Docetaxel - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Jiangsu Cancer Institute & Hospital | 73 | 2019-06-01 | 2019-04-30 |
| Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer Docetaxel, Nedaplatin, Endostar - Esophageal Cancer | Phase 2 | Unknown | First Affiliated Hospital of Guangxi Medical University | 186 | 2018-11-01 | 2018-08-28 |
| Rh-Endostatin (Endostar®) Continuous Intravenous Infusion Endostar, Docetaxel, Carboplatin - Lung Cancer | Phase 2 | Unknown | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 50 | 2018-10-01 | 2018-10-17 |
| Endostar First-line Treatment of Advanced NSCLC Endostar, Gemcitabine, Cisplatin - Non Small Cell Lung Cancer | Phase 2 | Unknown | China Medical University, China | 150 | 2017-04-01 | 2017-04-21 |
| Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC endostar, Placebos, radiotherapy - Non-small Cell Lung Cancer | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 50 | 2017-02-21 | 2018-08-03 |
| Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma recombinant human endostatin - Melanoma | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 70 | 2016-10-01 | 2017-03-29 |
| Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer Endostar, Chemotherapy - Breast Cancer | Phase 2 | Unknown | Zhejiang Cancer Hospital | 50 | 2016-06-30 | 2019-04-08 |
| A Trial of Endostar in Patients With Carcinoma of the Head and Neck Endostar - Nasopharyngeal Neoplasms | Phase 2 | Unknown | China International Medical Foundation | 24 | 2016-06-01 | 2019-01-31 |
| Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas NVB, DDP, Endostar - Esophageal Squamous Cell Carcinoma | Phase 2 | Unknown | Fudan University | 76 | 2016-01-01 | 2016-01-28 |
| Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma Endostar, 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor - Neuroblastoma | Phase 2 | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 60 | 2015-11-01 | 2016-06-14 |
| Endostar for Locally Recurrent Nasopharyngeal Carcinoma Endostatins, IMRT - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Sun Yat-sen University | 96 | 2015-11-01 | 2021-02-03 |
| A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC Recombinant Human Endostatin Injection (Endostar), Fluorouracil (5-Fu), Nedaplatin - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Yun-fei Xia | 328 | 2015-07-01 | 2017-12-22 |
Showing 20 of 36. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (6) · Nasopharyngeal Carcinoma (5) · Colorectal Neoplasms (3) · Lung Neoplasms (3) · Esophageal Neoplasms (2) · Lymphoma, T-Cell, Peripheral (2) · Melanoma (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Lymphoma, T-Cell (1) · Nasopharyngeal Neoplasms (1) · Neuroblastoma (1)
Zhejiang Cancer Hospital (5) · Fudan University (3) · Jiangsu Simcere Pharmaceutical Co., Ltd. (2) · Peking University Cancer Hospital & Institute (2) · Simcere Pharmaceutical Co., Ltd (2) · Sun Yat-sen University (2) · Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1) · China International Medical Foundation (1) · China Medical University, China (1) · Chinese Academy of Medical Sciences (1) · First Affiliated Hospital of Guangxi Medical University (1) · Jiangsu Cancer Institute & Hospital (1) · Jiangxi Provincial Cancer Hospital (1) · Nanjing First Hospital, Nanjing Medical University (1) · Nanjing NingQi Medicine Science and Technology Co., Ltd. (1)
China (33)
Xiaodong Jiang, MD (2) · Bin Li (1) · Fei Han, M.D., Ph.D. (1) · Hanmei Lou, PHD (1) · Jian Fang (1) · Junning Cao, MD (1) · Li Liang, MD (1) · Liming Zhu, MD (1) · Lin Yang, MD (1) · Ming Chen, Doctor (1) · Peng Yuan, MD (1) · Qiong Zhao, PhD (1) · Shenglin Ma, MD (1) · Sujia Wu, Dr. (1) · Sun Yan, MD (1)
PMID 15172975, PMID 22099051, PMID 22209574, PMID 22496834, PMID 22562140, PMID 23670576, PMID 25198661, PMID 25244494, PMID 25497558, PMID 26434908, PMID 27067521